38023298|t|PPARalpha agonist fenofibrate prevents postoperative cognitive dysfunction by enhancing fatty acid oxidation in mice.
38023298|a|Background: Due to high rates of incidence and disability, postoperative cognitive dysfunction (POCD) currently receives a lot of clinical attention. Disturbance of fatty acid oxidation is a potential pathophysiological manifestation underlying POCD. Peroxisome proliferator-activated receptor alpha (PPARalpha) is a significant transcription factor of fatty acid oxidation that facilitates the transfer of fatty acids into the mitochondria for oxidation. The potential role of PPARalpha intervention in POCD warrants consideration. Objective: The present study is aimed to investigate whether PPARalpha agonist fenofibrate (FF) could protect long-term isoflurane anesthesia-induced POCD model and to explore the potential underlying function of fatty acid oxidation in the process. Methods: We established the POCD model via 6 h long-term isoflurane anesthesia in vivo with C57BL/6J mice and in vitro with N2a cells. Cells and mice were pretreated with PPARalpha agonist FF before anesthesia, after which fatty acid oxidation and cognitive function were assessed. The level of fatty acid oxidation-related proteins was determined using western blotting. The contextual fear conditioning test was utilized to evaluate mice's learning and memory. Results: Our results showed that 6 h long-term isoflurane anesthesia induced contextual memory damage in mice, accompanied by decreases of fatty acid oxidation-related proteins (peroxisome proliferator-activated receptor gamma coactivator 1alpha, carnitine palmitoyltransferase 1A, and PPARalpha) both in the hippocampus of POCD mice and in N2a cells. In the N2a cell model, pretreatment of PPARalpha agonist FF led to the upregulation of fatty acid oxidation-related proteins. In vivo results showed that preconditioned FF reached similar effects. More crucially, FF has been shown to reduce cognitive damage in mice after long-term isoflurane anesthesia. Additionally, our data showed that after blocking fatty acid oxidation by Etomoxir, FF failed to protect cognitive function from long-term isoflurane anesthesia. Conclusions: Pretreatment of PPARalpha agonist FF can protect against long-term isoflurane anesthesia-induced POCD by enhancing fatty acid oxidation.
38023298	0	9	PPARalpha	Gene	19013
38023298	18	29	fenofibrate	Chemical	MESH:D011345
38023298	39	74	postoperative cognitive dysfunction	Disease	MESH:D000079690
38023298	88	98	fatty acid	Chemical	MESH:D005227
38023298	177	212	postoperative cognitive dysfunction	Disease	MESH:D000079690
38023298	214	218	POCD	Disease	MESH:D000079690
38023298	283	293	fatty acid	Chemical	MESH:D005227
38023298	363	367	POCD	Disease	MESH:D000079690
38023298	369	417	Peroxisome proliferator-activated receptor alpha	Gene	19013
38023298	419	428	PPARalpha	Gene	19013
38023298	471	481	fatty acid	Chemical	MESH:D005227
38023298	525	536	fatty acids	Chemical	MESH:D005227
38023298	596	605	PPARalpha	Gene	19013
38023298	622	626	POCD	Disease	MESH:D000079690
38023298	712	721	PPARalpha	Gene	19013
38023298	730	741	fenofibrate	Chemical	MESH:D011345
38023298	743	745	FF	Chemical	MESH:D011345
38023298	771	781	isoflurane	Chemical	MESH:D007530
38023298	801	805	POCD	Disease	MESH:D000079690
38023298	864	874	fatty acid	Chemical	MESH:D005227
38023298	929	933	POCD	Disease	MESH:D000079690
38023298	958	968	isoflurane	Chemical	MESH:D007530
38023298	993	1001	C57BL/6J	CellLine	CVCL:C0MW
38023298	1025	1028	N2a	CellLine	CVCL:0470
38023298	1072	1081	PPARalpha	Gene	19013
38023298	1090	1092	FF	Chemical	MESH:D011345
38023298	1124	1134	fatty acid	Chemical	MESH:D005227
38023298	1196	1206	fatty acid	Chemical	MESH:D005227
38023298	1411	1421	isoflurane	Chemical	MESH:D007530
38023298	1452	1465	memory damage	Disease	MESH:D008569
38023298	1503	1513	fatty acid	Chemical	MESH:D005227
38023298	1542	1609	peroxisome proliferator-activated receptor gamma coactivator 1alpha	Gene	19017
38023298	1650	1659	PPARalpha	Gene	19013
38023298	1688	1692	POCD	Disease	MESH:D000079690
38023298	1705	1708	N2a	CellLine	CVCL:0470
38023298	1723	1726	N2a	CellLine	CVCL:0470
38023298	1755	1764	PPARalpha	Gene	19013
38023298	1773	1775	FF	Chemical	MESH:D011345
38023298	1803	1813	fatty acid	Chemical	MESH:D005227
38023298	1885	1887	FF	Chemical	MESH:D011345
38023298	1929	1931	FF	Chemical	MESH:D011345
38023298	1957	1973	cognitive damage	Disease	MESH:D003072
38023298	1998	2008	isoflurane	Chemical	MESH:D007530
38023298	2071	2081	fatty acid	Chemical	MESH:D005227
38023298	2095	2103	Etomoxir	Chemical	MESH:C054207
38023298	2105	2107	FF	Chemical	MESH:D011345
38023298	2160	2170	isoflurane	Chemical	MESH:D007530
38023298	2212	2221	PPARalpha	Gene	19013
38023298	2230	2232	FF	Chemical	MESH:D011345
38023298	2263	2273	isoflurane	Chemical	MESH:D007530
38023298	2293	2297	POCD	Disease	MESH:D000079690
38023298	2311	2321	fatty acid	Chemical	MESH:D005227
38023298	Positive_Correlation	MESH:D007530	MESH:D008569
38023298	Positive_Correlation	MESH:D005227	MESH:D011345
38023298	Positive_Correlation	MESH:D007530	MESH:D003072
38023298	Negative_Correlation	MESH:C054207	MESH:D005227
38023298	Association	MESH:D005227	19017
38023298	Association	MESH:D000079690	19017
38023298	Negative_Correlation	MESH:D008569	19013
38023298	Negative_Correlation	MESH:D005227	MESH:D008569
38023298	Association	MESH:D005227	19013
38023298	Association	MESH:D005227	MESH:D000079690
38023298	Negative_Correlation	MESH:D007530	MESH:D011345
38023298	Negative_Correlation	MESH:D007530	19017
38023298	Positive_Correlation	MESH:D011345	19013
38023298	Negative_Correlation	MESH:D000079690	19013
38023298	Negative_Correlation	MESH:D011345	MESH:D000079690
38023298	Negative_Correlation	MESH:D005227	MESH:D007530
38023298	Negative_Correlation	MESH:C054207	MESH:D000079690
38023298	Negative_Correlation	MESH:D011345	MESH:D003072
38023298	Negative_Correlation	MESH:D007530	19013
38023298	Positive_Correlation	MESH:D007530	MESH:D000079690

